MedTrace Logo

Emotional Evaluation and Reconstructed Breast Satisfaction

NCT03777852 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2019-04-16

No results posted yet for this study

Summary

Data from the National Cancer Institute (Inca) reveal that breast cancer is the most common type of cancer among women worldwide. In Brazil, it is second only to non-melanoma skin cancer. Breast cancer is a feared disease in the female universe because it is considered one of the major causes of death due to neoplasia among women. It brings also the stigma of suffering, mutilation, loss of female identity and loss of body contour. Among other issues, problems with body self-image may have an impact on sexuality and fertility, and also, the incapacity to breastfeed. Breast reconstruction can restore the patient's shape and physical integrity, among other benefits. The research justifies itself because information about the satisfaction of breast reconstruction can be achieved. It is also known that women having breast reconstruction after a mastectomy due to cancer have a favorable evolution. This study will analyze body contour satisfaction of women undergoing mastectomy and breast reconstruction as part of their breast cancer treatment. The Breast Q questionnaire will be used to measure patients satisfaction.

Conditions

  • Malignant Neoplasm of the Breast

Interventions

DIAGNOSTIC_TEST

First Questionnaire application

Women with breast cancer will respond to the First Breast Q questionnaire before treatment with breast cancer reconstruction surgery.

DIAGNOSTIC_TEST

Second Questionnaire application

Women with breast cancer will respond to the Second Breast Q questionnaire after treatment with breast cancer reconstruction surgery.

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Helio HA Carrara, MD, PhD · Gynecology & Obstetrics Departament, Ribeirão Preto Medical School, USP.

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2021-02-28
Completion
2022-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03777852 on ClinicalTrials.gov